Government reduced the price of 41 life saving medicines by more than 50 percent

New Delhi: The government will reduce the prices of 41 widely used life-saving medicines and this will provide relief to the common people. The government has reduced the prices of 41 well-known medicines and six formulations used in diabetes, heart disease, liver and other diseases. The National Pharmaceutical Pricing Authority (NPPA) took the decision to reduce the price.

According to the notification of the pharmaceutical department, the prices of multi vitamins and antibiotics used in the treatment of diabetes, body pain, cardiovascular conditions, liver, antacids, infections and allergies have been reduced.

There are more than ten crore diabetic patients in India. Thus, India has one of the countries with the highest number of diabetic patients in the world. Therefore, diabetic patients will greatly benefit from the reduction in drug prices. Insulin dependent patients will greatly benefit from the reduction in drug prices.

A senior NPPA official said that changing the prices of drugs and formulations is a normal procedure for a regulatory body like NPPA. By fixing its price we ensure that this medicine remains affordable to the public.

The price of Dapaglifosin Metformin Hydrochloride Tablet, which lowers blood glucose levels by reducing the production of glucose in the liver, has been reduced from Rs 30 to Rs 16.

The price of compounds like budesonide and formoterol, which improve lung function by controlling asthma symptoms, has been reduced to Rs 6.62 per dose. Usually its 120 dose bottle costs Rs 3,800. Similarly, hydrochlorothiazide, a drug used to lower blood pressure, is priced at Rs. It was reduced to Rs 11.07. It's 10.45. The price of infection medicines Ceftazidime and Avibactam has been reduced from Rs 4,000 to Rs 1,569.94 per vial. The price of Antacid Antigas Gel has reduced from Rs 2.57 to Rs 0.56 per ml.

The prices of Atorvastatin, Clopidogrel and Aspirin capsules have been reduced from Rs 30 to Rs 13.84 per capsule. Earlier, the cost of general treatment was high due to the high cost of multivitamins and antibiotics. Last month, the Department of Pharmaceuticals had revised the price limits of 923 drug formulations. Along with this, the retail prices of 65 formulations were revised. This change has come into effect from April 1.

Earlier this year, the NPP had reduced the prices of 69 medicines used in diabetes and hypertension.